Our First Investment: Molecular Attraction

Mosquitoes feeding on patented stimulant

We're proud to announce our inaugural investment in Molecular Attraction through the UpRoot Capital Syndicate. The Swedish pre-seed biotech is developing a novel pesticide alternative capable of managing large-scale mosquito populations without environmental collateral.

Leveraging advanced sex pheromone synthesis, Molecular Attraction's platform disrupts the breeding cycles of invasive species—a critical capability as climate change accelerates vector migration. The technology achieves marked population reductions in field trials by releasing synthetic male mosquito pheromones continuously, causing behavioral disruption that exhausts males and damages female reproductive organs.

With mosquito populations representing a self-replicating market force, the industry requires solutions that scale as fast as the problem itself. Traditional chemical pesticides face mounting regulatory restrictions and accelerating resistance. Molecular Attraction delivers a scientifically robust, non-toxic alternative that protects both human health and natural capital while maintaining cost parity with traditional approaches.

As our first portfolio company, Molecular Attraction perfectly illustrates the UpRoot thesis: backing definitive counter-measures to biological volatility. True climate resilience requires moving beyond reaction and towards proactive, biologically intelligent control systems.